Strata Critical Medical, Inc. Class A Common Stock (SRTA) is a publicly traded the market company. As of May 21, 2026, SRTA trades at $5.41 with a market cap of $464.65M and a P/E ratio of 11.01. SRTA moved +6.13% today. Year to date, SRTA is -1.77%; over the trailing twelve months it is flat. Its 52-week range spans $3.85 to $6.02. Analyst consensus is strong buy with an average price target of $9.17. Rallies surfaces SRTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for SRTA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.41 |
| Market Cap | $464.65M |
| P/E Ratio | 11.01 |
| EPS | $0.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.02 |
| 52-Week Low | $3.85 |
| Volume | 737.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $197.14M |
| Net Income | $41.35M |
| Gross Margin | 20.86% |
4 analysts cover SRTA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.17.